share_log
Moomoo 24/7 ·  Nov 7, 2023 08:30
Salarius Completes FDA Type B Meeting For Seclidemstat Ewing Sarcoma Development Program
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment